Revvity, Inc. (RVTY)

From the record

Revvity, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Revvity, Inc.'s 10 filed years say what it did: revenue went from $2.1 billion in fiscal 2017 to $2.9 billion in fiscal 2025, up 3.4% a year; it rose in 6 of 9 years; the deepest fall was 28% from fiscal 2022 to fiscal 2023; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-28, Revvity, Inc.'s diluted share count shrank about 2.7% a year, and dividends and buybacks returned about 100% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 17 sales (16 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-10-02 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-28, Revvity, Inc. earned about 3 cents of profit for every dollar of shareholders' money. Leverage: it owed about 40 cents per dollar of assets, and net share issuance: its share count shrank 5.1% over the year (the filed statements).

From the record

Revvity, Inc.'s standing among 21 graded names in its industry family: revenue of $2.9 billion in fiscal 2025 ranks in the top 31% by size; a net margin of 8.4% ranks in the top 26%; revenue growth of -4.8% a year over the last 3 filed years ranks in the bottom 13% (its annual reports).

From the record

Revvity, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Singh, Prahlad R. (President, Chief Executive Officer and Director, as filed), filing under that title since 2020-01-31, 6.8 years (top 18% of its family); the 15 officers and directors filing in the last fifteen months have been on the record a median of 8.8 years (top 7%); 2 officer or director changes were reported on Form 8-K since 2023-11-13, against the 15 people in charge now (top 2%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Revvity, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $920 million against debt of $2.6 billion leaves -14.1% of its assets as net cash, bottom 20% of its family; cash from operations less capital spending is 17.8% of revenue (top 17%); research spending of 7.6% of revenue (bottom 23%) (its annual report).

From the record

Revvity, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -4.8% a year over the last three filed years against 3.4% over all 10, slowing (bottom 48% of its family); the newest year grew 3.7% (top 45%); research spending grew -0.9% a year (bottom 43%); capital spending grew -5% a year (top 37%) (its annual reports). Revvity, Inc. reported 2 lines of business in fiscal 2025: Life Sciences at $1.4 billion (50%), Diagnostics at $1.4 billion (50%); 2 of 2 grew against the year before (its annual report).

From the record

Revvity, Inc.'s newest year against its own record: revenue of $2.9 billion in fiscal 2025 came in 13.7% above the $2.5 billion its prior three years' pace pointed to (top 7% of its family); net income of $241 million against a prior three-year average of $511 million (bottom 38%); a net margin of 8.4% against 17.4% before (bottom 43%) (its annual reports).